Erratum: Memantine (Ebixa) for dementia in moderately severe Alzheimer’s disease

Published 2008-12-01 00:00:00

Information on the dose titration of memantine contained in Table 1 of the August 2008 NPS RADAR review of memantine was incorrect. The dose for the tablet formulation was correct but the dose for the oral solution was mistakenly halved.

The error has been rectified on the NPS website and all electronic copies of the review now show the correct dose (Table 1). We apologise for any confusion.

Table 1: Initial dose titration

Week

Dose

Week 1

Morning: half a tablet or 10 drops of solution

Week 2

Morning: half a tablet or 10 drops of solution

Evening: half a tablet or 10 drops of solution

Week 3

Morning: 1 tablet or 20 drops of solution

Evening: half a tablet or 10 drops of solution

Week 4

Morning: 1 tablet or 20 drops of solution

Evening: 1 tablet or 20 drops of solution

 

Published 2008-12-01 00:00:00

The information contained in this material is derived from a critical analysis of a wide range of authoritative evidence. Any treatment decisions based on this information should be made in the context of the clinical circumstances of each patient.

This site complies to the HONcode standard for trustworthy health information: verify here.
Health Insite Logo This website is certified by Health On the Net Foundation. Click to verify.